Physician profile
Michelle D Palazzo
NPI 1922008747
$7,187.81
in general payments reported to CMS, 2019-2025
23 companies · $1,089 in 2025
The $1,089 reported for 2025 was more than what 75% of Hand Surgery providers received nationally (typical 2025 total: $270).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $865 · 2020: $316 · 2021: $693 · 2022: $1,941 · 2023: $1,407 · 2024: $877 · 2025: $1,089.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,330 · Education: $43.25.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,329.71 |
| Education | $43.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rti Surgical, INC | $2,544.16 | 2022-2025 | |
| Allergan, INC. | $1,158.00 | 2019-2022 | |
| Axogen | $816.23 | 2019-2025 | Avance Nerve Graft |
| Sientra, INC. | $483.28 | 2020-2022 | |
| Abbvie INC. | $344.46 | 2023-2025 | |
| Integra Lifesciences Corporation | $336.15 | 2020-2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Smith+Nephew, INC. | $231.83 | 2023-2024 | Stravix, Pico, Renasys Touch |
| Stryker Corporation | $173.84 | 2021 | |
| Mentor Worldwide LLC | $150.58 | 2025 | Mentor Memorygel Resterilizable Gel Sizer |
| Boston Scientific Corporation | $131.14 | 2022 | |
| Polarityte, INC. | $118.76 | 2019 | |
| Tela Bio, INC. | $114.15 | 2020-2022 | |
| Endo Pharmaceuticals INC. | $114.03 | 2019-2022 | |
| Musculoskeletal Transplant Foundation INC. | $101.63 | 2020 | |
| Heron Therapeutics, INC. | $99.64 | 2023 | Zynrelef |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acera Surgical, INC. | $79.30 | 2021 | |
| Galderma Laboratories, L.P. | $56.15 | 2019-2023 | |
| Astrazeneca Pharmaceuticals LP | $43.25 | 2025 | Enhertu |
| Kerecis Limited | $21.67 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide, Kerecis Omega3 Surgiclose |
| Sanara Medtech INC. | $21.19 | 2023 | Celleraterx |
| Endo USA, INC. | $18.29 | 2025 | Xiaflex |
| Polynovo North America LLC | $17.02 | 2025 | Novosorb Btm |
| Skeletal Dynamics INC | $13.06 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michelle Palazzo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.